Page 2 - Precision Flow Plus News Today

Vapotherm (NYSE:VAPO – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Valuation & Earnings This table compares Vapotherm and Artivion’s gross revenue, […]

Vapotherm, Inc. (NYSE:NYSE:VAPO) Q3 2022 Earnings Conference Call November 2, 2022 16:30 ET Company Participants Mark Klausner - Westwicke Partners Joe Army - President & Chief...

Vapotherm, Inc. (NYSE:NYSE:VAPO) Q2 2022 Earnings Conference Call August 03, 2022 04:30 PM ET Company Participants Mark Klausner - Westwicke Partners Joe Army - President and Chief...

Vapotherm (NYSE:VAPO – Get Rating) and Alphatec (NASDAQ:ATEC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Institutional and Insider Ownership 69.7% of Vapotherm shares are held by […]

Wall Street analysts predict that Vapotherm, Inc. (NYSE:VAPO – Get Rating) will post sales of $19.34 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Vapotherm’s earnings, with the highest sales estimate coming in at $19.98 million and the lowest estimate coming in at $18.70 million. Vapotherm posted […]

Vapotherm (NYSE:VAPO – Get Rating) and Asensus Surgical (NYSE:ASXC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Valuation and Earnings This table compares Vapotherm and Asensus Surgical’s […]

Vapotherm (NYSE:VAPO – Get Rating) had its target price lowered by Piper Sandler from $5.00 to $2.50 in a research report released on Thursday morning, The Fly reports. The brokerage currently has an underweight rating on the stock. VAPO has been the topic of a number of other reports. Zacks Investment Research downgraded shares of […]

Vapotherm (NYSE:VAPO – Get Rating) had its price objective reduced by equities researchers at Piper Sandler from $5.00 to $2.50 in a research note issued on Thursday, The Fly reports. Piper Sandler’s price target points to a potential downside of 15.25% from the stock’s previous close. VAPO has been the subject of a number of […]

Vapotherm, Inc. (NYSE:VAPO – Get Rating) CFO John Landry bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 24th. The shares were purchased at an average cost of $2.90 per share, for a total transaction of $14,500.00. Following the transaction, the chief financial officer now owns 128,074 shares in the company, […]

Vapotherm (NYSE:VAPO – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company […]